Products Brought to Market

One of the Foundation’s missions is to transfer resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products. The following medical products, which have been developed utilizing discoveries by the Clayton Foundation or its supporting organizations, have been brought to market.

Exparel

Post-surgical non-opioid pain relief

Exparel uses DepoFoam®, a proven product delivery technology, to deliver bupivacaine over 72 hours.

  • Bupivacaine liposome injectable suspension
  • Post-operative pain
Learn More

DepoDur

Drug for time-released pain control

Depodur is the only extended-release morphine sulphate approved for epidural use in the treatment of postsurgical pain.

  • Morphine liposome injectable suspension
  • Post-operative pain

Depocyt

Therapeutic drug for cancer

DEPOCYT is a sustained release formulation of cytarabine approved for the treatment of lymphomatous meningitis.

  • Cytarabine liposomes injectable suspension
  • Lymphomatous and solid tumor meningitis
Learn More

Kymriah

  • Car-T cell therapy
  • B-cell acute lymphoblastic leukemia
Learn More

Zynteglo

  • autologous CD34+ cells encoding βA-T87Q-globin gene
  • Beta-Thalassemia
Learn More

Attrius

  • Cardiac PET Imaging
  • Medical imaging systems for private practices
Learn More

RetCam3 & RetCam Shuttle

RetCam3 and RetCam Shuttle are major achievements in providing minaturized, integrated, wide-field imaging for management of eye disorders in infants.

  • Neonatal and pediatric imaging system
  • Wide-field digital imaging system for the hospital and clinic
Learn More

Accuplex 4

The AccuPlex4 test for heartworm and the pathogens that cause Lyme disease, ehrlichiosis and anaplasmosis offers significant improvements in sensitivity and specificity over existing screening tests.

  • Ehrlichoisis canine
  • Assay for canine vector borne diseases

SCA6 Diagnostic Tests

Neurogenetic diagnostic assay

Ataxia is characterized by poor coordination of hand, speech and eye movements, uncoordinated and unsteady gait. The test detects the triplet repeat expansion in nine known genes causing cerebellar ataxia, CAG triple repeat expansion in the SCA6 gene.

  • Ataxia diagnostic
  • Assay for Spinocerebellar ataxia type 6 (SCA6)
Learn More

FIA – Functional Intracellular Analysis

Lymphocyte blood assay

SpectraCell’s FIA™ is a clinically effective diagnostic tool for the prevention and management of chronic disease conditions.

  • Functional Intracellular analysis
  • Assay for intracellular function of essential micronutrien
Learn More